Surgical site peptidylarginine deaminase 4 (PAD4), a biomarker of NETosis, correlates with insulin resistance in total joint arthroplasty patients: A preliminary report.

While obesity and insulin resistance are known risk factors for wound complications after total joint arthroplasty (TJA), the biologic causes remain to be elucidated. Recently, neutrophil extracellular trap formation (NETosis) was identified as a mediator of delayed wound healing in insulin resistan...

Full description

Bibliographic Details
Main Authors: Vitor F Martins, Christopher R Dobson, Maedha Begur, Jesal Parekh, Scott T Ball, Francis Gonzalez, Jan M Hughes-Austin, Simon Schenk
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0245594
_version_ 1818261869425590272
author Vitor F Martins
Christopher R Dobson
Maedha Begur
Jesal Parekh
Scott T Ball
Francis Gonzalez
Jan M Hughes-Austin
Simon Schenk
author_facet Vitor F Martins
Christopher R Dobson
Maedha Begur
Jesal Parekh
Scott T Ball
Francis Gonzalez
Jan M Hughes-Austin
Simon Schenk
author_sort Vitor F Martins
collection DOAJ
description While obesity and insulin resistance are known risk factors for wound complications after total joint arthroplasty (TJA), the biologic causes remain to be elucidated. Recently, neutrophil extracellular trap formation (NETosis) was identified as a mediator of delayed wound healing in insulin resistant states. Herein, we explored the relationship between obesity, insulin resistance and biomarkers of NET formation in TJA subjects. We enrolled 14 obese (body mass index [BMI]≥30 kg/m2), and 15 lean (BMI<30 kg/m2) subjects undergoing primary knee or hip TJA. On the day of surgery, skeletal muscle proximal to the operated joint and plasma were collected. Protein abundance of NETosis biomarkers, peptidylarginine deaminase 4 (PAD4) and neutrophil elastase (NE) were assessed in skeletal muscle by immunoblotting and metabolic parameters (glucose, insulin, triglycerides, free fatty acids) and cell-free double-stranded DNA (cf-dsDNA) were assessed in plasma and were correlated with obesity and insulin resistance (as measured by the homeostatic model assessment for insulin resistance). When comparing lean and obese subjects, there were no significant differences in plasma cf-dsDNA or skeletal muscle NE or PAD4 abundance. In contrast, skeletal muscle PAD4 abundance, but not NE or plasma cf-dsDNA, was positively correlated with insulin resistance. Compared to insulin sensitive subjects, insulin resistant TJA subjects have higher expression of PAD4 at the surgical site and therefore may have higher rates of NET formation, which may lead to delayed surgical site wound healing.
first_indexed 2024-12-12T18:54:05Z
format Article
id doaj.art-473d57937438404f88697861fea8cb8c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T18:54:05Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-473d57937438404f88697861fea8cb8c2022-12-22T00:15:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024559410.1371/journal.pone.0245594Surgical site peptidylarginine deaminase 4 (PAD4), a biomarker of NETosis, correlates with insulin resistance in total joint arthroplasty patients: A preliminary report.Vitor F MartinsChristopher R DobsonMaedha BegurJesal ParekhScott T BallFrancis GonzalezJan M Hughes-AustinSimon SchenkWhile obesity and insulin resistance are known risk factors for wound complications after total joint arthroplasty (TJA), the biologic causes remain to be elucidated. Recently, neutrophil extracellular trap formation (NETosis) was identified as a mediator of delayed wound healing in insulin resistant states. Herein, we explored the relationship between obesity, insulin resistance and biomarkers of NET formation in TJA subjects. We enrolled 14 obese (body mass index [BMI]≥30 kg/m2), and 15 lean (BMI<30 kg/m2) subjects undergoing primary knee or hip TJA. On the day of surgery, skeletal muscle proximal to the operated joint and plasma were collected. Protein abundance of NETosis biomarkers, peptidylarginine deaminase 4 (PAD4) and neutrophil elastase (NE) were assessed in skeletal muscle by immunoblotting and metabolic parameters (glucose, insulin, triglycerides, free fatty acids) and cell-free double-stranded DNA (cf-dsDNA) were assessed in plasma and were correlated with obesity and insulin resistance (as measured by the homeostatic model assessment for insulin resistance). When comparing lean and obese subjects, there were no significant differences in plasma cf-dsDNA or skeletal muscle NE or PAD4 abundance. In contrast, skeletal muscle PAD4 abundance, but not NE or plasma cf-dsDNA, was positively correlated with insulin resistance. Compared to insulin sensitive subjects, insulin resistant TJA subjects have higher expression of PAD4 at the surgical site and therefore may have higher rates of NET formation, which may lead to delayed surgical site wound healing.https://doi.org/10.1371/journal.pone.0245594
spellingShingle Vitor F Martins
Christopher R Dobson
Maedha Begur
Jesal Parekh
Scott T Ball
Francis Gonzalez
Jan M Hughes-Austin
Simon Schenk
Surgical site peptidylarginine deaminase 4 (PAD4), a biomarker of NETosis, correlates with insulin resistance in total joint arthroplasty patients: A preliminary report.
PLoS ONE
title Surgical site peptidylarginine deaminase 4 (PAD4), a biomarker of NETosis, correlates with insulin resistance in total joint arthroplasty patients: A preliminary report.
title_full Surgical site peptidylarginine deaminase 4 (PAD4), a biomarker of NETosis, correlates with insulin resistance in total joint arthroplasty patients: A preliminary report.
title_fullStr Surgical site peptidylarginine deaminase 4 (PAD4), a biomarker of NETosis, correlates with insulin resistance in total joint arthroplasty patients: A preliminary report.
title_full_unstemmed Surgical site peptidylarginine deaminase 4 (PAD4), a biomarker of NETosis, correlates with insulin resistance in total joint arthroplasty patients: A preliminary report.
title_short Surgical site peptidylarginine deaminase 4 (PAD4), a biomarker of NETosis, correlates with insulin resistance in total joint arthroplasty patients: A preliminary report.
title_sort surgical site peptidylarginine deaminase 4 pad4 a biomarker of netosis correlates with insulin resistance in total joint arthroplasty patients a preliminary report
url https://doi.org/10.1371/journal.pone.0245594
work_keys_str_mv AT vitorfmartins surgicalsitepeptidylargininedeaminase4pad4abiomarkerofnetosiscorrelateswithinsulinresistanceintotaljointarthroplastypatientsapreliminaryreport
AT christopherrdobson surgicalsitepeptidylargininedeaminase4pad4abiomarkerofnetosiscorrelateswithinsulinresistanceintotaljointarthroplastypatientsapreliminaryreport
AT maedhabegur surgicalsitepeptidylargininedeaminase4pad4abiomarkerofnetosiscorrelateswithinsulinresistanceintotaljointarthroplastypatientsapreliminaryreport
AT jesalparekh surgicalsitepeptidylargininedeaminase4pad4abiomarkerofnetosiscorrelateswithinsulinresistanceintotaljointarthroplastypatientsapreliminaryreport
AT scotttball surgicalsitepeptidylargininedeaminase4pad4abiomarkerofnetosiscorrelateswithinsulinresistanceintotaljointarthroplastypatientsapreliminaryreport
AT francisgonzalez surgicalsitepeptidylargininedeaminase4pad4abiomarkerofnetosiscorrelateswithinsulinresistanceintotaljointarthroplastypatientsapreliminaryreport
AT janmhughesaustin surgicalsitepeptidylargininedeaminase4pad4abiomarkerofnetosiscorrelateswithinsulinresistanceintotaljointarthroplastypatientsapreliminaryreport
AT simonschenk surgicalsitepeptidylargininedeaminase4pad4abiomarkerofnetosiscorrelateswithinsulinresistanceintotaljointarthroplastypatientsapreliminaryreport